Nucana Plc (NCNA)

Nucana (NCNA) Stock Price & Analysis


NCNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.52 - $2.24
Previous Close$0.89
Average Volume (3M)156.83K
Market Cap
Enterprise Value-$10.52M
Total Cash (Recent Filing)£46.53M
Total Debt (Recent Filing)£236.00K
Price to Earnings (P/E)-1.2
May 17, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.77
Shares Outstanding52,196,000
10 Day Avg. Volume379,197
30 Day Avg. Volume156,830
Standard Deviation0.33
Financial Highlights & Ratios
Price to Book (P/B)1.27
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-4.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Price Target Upside552.17% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Nucana Plc’s price range in the past 12 months?
Nucana Plc lowest stock price was $0.52 and its highest was $2.24 in the past 12 months.
    What is Nucana Plc’s market cap?
    Currently, no data Available
    When is Nucana Plc’s upcoming earnings report date?
    Nucana Plc’s upcoming earnings report date is May 17, 2023 which is in 48 days.
      How were Nucana Plc’s earnings last quarter?
      Currently, no data Available
      Is Nucana Plc overvalued?
      According to Wall Street analysts Nucana Plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Nucana Plc pay dividends?
        Nucana Plc does not currently pay dividends.
        What is Nucana Plc’s EPS estimate?
        Nucana Plc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does Nucana Plc have?
        Nucana Plc has 52,179,977 shares outstanding.
          What happened to Nucana Plc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of Nucana Plc?
          Among the largest hedge funds holding Nucana Plc’s share is Wildcat Capital Management, Llc. It holds Nucana Plc’s shares valued at N/A.


            Nucana Stock Smart Score

            The Nucana stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
            Learn more about TipRanks Smart Score

            Company Description

            Nucana Plc

            NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology is consists of acelarin, NUC-3373, and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.


            Forecast EPS vs Actual EPS

            Currently, no data available
            Please return soon. This page is being updated.

            Similar Stocks
            Price & Change
            Arecor Therapeutics PLC
            Tiziana Life Sciences
            Orchard Therapeutics
            Aptamer Group Plc

            Popular Stocks

            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis